Article
Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.
Nature reviews. Endocrinology - 1 Jun 2015
Yang Xilin, Lee Heung M, Chan Juliana C N
Abstract excerpt
On the basis of data obtained from a prospective cohort of Chinese patients with type 2 diabetes mellitus (T2DM), we discuss cancer subphenotypes (risk factors) in patients with T2DM, which can lead to drug-cancer subphenotype interactions. These subphenotypes include HDL cholesterol levels <1.0 mmol/l, co-occurrence of LDL cholesterol levels <2.8 mmol/l and triglyceride levels <1.7 mmol/l, and co-occurrence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.